Ras Mutational Status Is a Biomarker for Resistance to EGFR Inhibitors in Colorectal Carcinoma

WOLFRAM C.M. DEMPKE; VOLKER HEINEMANN

Review ArticleClinical StudiesR

Ras Mutational Status Is a Biomarker for Resistance to EGFR Inhibitors in Colorectal Carcinoma

WOLFRAM C.M. DEMPKE and VOLKER HEINEMANN

Anticancer Research November 2010, 30 (11) 4673-4677;

WOLFRAM C.M. DEMPKE

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: wolfram.dempke{at}elblandkliniken.de

VOLKER HEINEMANN

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Tables

Download figure
Open in new tab
Download powerpoint
Figure 1.
Cascade of EGFR- and ras-modulated signal transduction.

Tables

Figures

PreviousNext

In this issue

Anticancer Research

Vol. 30, Issue 11

November 2010

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Ras Mutational Status Is a Biomarker for Resistance to EGFR Inhibitors in Colorectal Carcinoma

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 3 + 3 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Ras Mutational Status Is a Biomarker for Resistance to EGFR Inhibitors in Colorectal Carcinoma

WOLFRAM C.M. DEMPKE, VOLKER HEINEMANN

Anticancer Research Nov 2010, 30 (11) 4673-4677;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Ras Mutational Status Is a Biomarker for Resistance to EGFR Inhibitors in Colorectal Carcinoma

WOLFRAM C.M. DEMPKE, VOLKER HEINEMANN

Anticancer Research Nov 2010, 30 (11) 4673-4677;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Cancer cell states and emergent properties of the dynamic tumor system
Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer
GA201 (RG7160): A Novel, Humanized, Glycoengineered Anti-EGFR Antibody with Enhanced ADCC and Superior In Vivo Efficacy Compared with Cetuximab

Google Scholar

Main menu

User menu

Search

Ras Mutational Status Is a Biomarker for Resistance to EGFR Inhibitors in Colorectal Carcinoma

Article Figures & Data

Figures

Tables

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section